 - Participant has a bleeding disorder or is on anti-coagulation therapy that results in a platelet count less than 20,000μL or International Normalized Ration INR 2X control, or who, in the opinion of the investigator would be at significant risk of increased bleeding or bruising as a result of SC therapy 